🧪
hypothesis

Synaptic Vesicle Protein Phosphorylation Reprograms Release Probability and Interacts with APP Processing

Hypothesis

Synaptic Vesicle Protein Phosphorylation Reprograms Release Probability and Interacts with APP Processing

Synaptic activity-dependent phosphorylation of synapsin-1 by CamKII and calcineurin dynamically regulates vesicle mobilization, while Cdk5-mediated phosphorylation of synaptophysin and SV2A facilitates interaction with APP in presynaptic.
🧬 SYN1 (Synapsin-1)🩺 neurodegeneration🎯 Composite 46%💱 $0.52▲5.3%active
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 1 oppose
✓ All Quality Gates Passed
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite46%

🧪 Overview

Synaptic activity-dependent phosphorylation of synapsin-1 by CamKII and calcineurin dynamically regulates vesicle mobilization, while Cdk5-mediated phosphorylation of synaptophysin and SV2A facilitates interaction with APP in presynaptic terminals, creating a hub where impaired neurotransmitter release converges with local Aβ secretion.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Synaptic Activity<br/>Calcium Influx at Active Zone"]
    B["CamKII Activation<br/>Synapsin-1 SYN1 Phosphorylation"]
    C["SYN1 Dissociates from Reserve Pool<br/>Vesicle Mobilization"]
    D["Calcineurin Dephosphorylation<br/>Feedback Vesicle Reclustering"]
    E["Cdk5 Aberrant Activation<br/>SYN1 SV2A Synaptophysin Phosphorylation"]
    F["Release Probability Reprogrammed<br/>Short-Term Plasticity Disrupted"]
    G["APP Processing Modulated<br/>Secretase Access Altered by Vesicle State"]
    H["Synaptic Dysfunction<br/>AD ALS Co-pathology"]
    A --> B
    B --> C
    C --> D
    D --> B
    E --> F
    F --> G
    E --> H
    G --> H
    style E fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports1 contradicts
Supports
Autophagy and apoptosis dysfunction in neurodegenerative disorders.
Prog Neurobiol2014PMID:24211851medium
Supports
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
Neurol Res2017PMID:27809706medium
Supports
Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Prog Neurobiol2013PMID:23827971medium
Supports
TDP-43 toxic gain of function links ALS, FTD and Alzheimer's Disease through splicing dysregulation.
bioRxiv2025PMID:40654715medium
Supports
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies.
J Peripher Nerv Syst2025PMID:40099640medium
Contradicts
Role of SNAREs in Neurodegenerative Diseases.
Cells2021PMID:33922505medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SYN1

No curated PDB or AlphaFold mapping for SYN1 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SYN1 (Synapsin-1) →

No DepMap CRISPR Chronos data found for SYN1 (Synapsin-1).

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0512
Events (7d)
0
Price History
▲5.3%

💾 Resource Usage

LLM Tokens
7,768
$0.0265
Total Cost
$0.0265

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF we pharmacologically inhibit Cdk5 activity (using roscovitine) in primary hippocampal neurons AND simultaneously measure synaptic vesicle release probability (via FM4-64 destaining assays) and extrCdk5 inhibition will reduce extracellular Aβ42 concentration by ≥40% while release probability remains within ±15% of baseline, demonstrating dissociable effect— no observation —pending0.75
IF we express synapsin-1 S9A phospho-mutant (non-phosphorylatable) in synapsin-1/2 double knockout neurons via viral transduction AND compare to wild-type synapsin-1 rescue, THEN the phospho-mutant wiS9A-expressing neurons will show ≥50% reduction in synaptic vesicle mobilization (measured as refractory pool replenishment rate) and ≥40% reduction in synaptop— no observation —pending0.68
🔮 Falsifiable Predictions (2)
pendingconf 75%
IF we pharmacologically inhibit Cdk5 activity (using roscovitine) in primary hippocampal neurons AND simultaneously measure synaptic vesicle release probability (via FM4-64 destaining assays) and extracellular Aβ42 levels (via ELISA), THEN neurons will exhibit significantly reduced Aβ42 secretion (≥
Predicted outcome: Cdk5 inhibition will reduce extracellular Aβ42 concentration by ≥40% while release probability remains within ±15% of baseline, demonstrating dissocia
Falsification: If Cdk5 inhibition produces equivalent changes in both release probability AND Aβ secretion (i.e., both change by >30% in the same direction), this would indicate these processes are not independently
pendingconf 68%
IF we express synapsin-1 S9A phospho-mutant (non-phosphorylatable) in synapsin-1/2 double knockout neurons via viral transduction AND compare to wild-type synapsin-1 rescue, THEN the phospho-mutant will demonstrate both reduced synaptic vesicle mobilization during prolonged stimulation AND decreased
Predicted outcome: S9A-expressing neurons will show ≥50% reduction in synaptic vesicle mobilization (measured as refractory pool replenishment rate) and ≥40% reduction i
Falsification: If the S9A mutant shows normal vesicle mobilization but still demonstrates reduced APP interaction, this would indicate synapsin-1 phosphorylation regulates APP processing independently of vesicle dyn
View on SciDEX ↗